SIP1 inhibitors constitute a specialized group of compounds meticulously crafted to selectively target and impede the activity of Smad-interacting protein 1 (SIP1), also recognized as ZEB2. As a transcription factor, SIP1 intricately participates in pivotal cellular processes encompassing embryonic development, epithelial-to-mesenchymal transition (EMT), and the nuanced regulation of gene expression. Its intricate involvement positions SIP1 as a master regulator, orchestrating the delicate balance between cell adhesion and migration-a critical equilibrium integral to normal tissue development and homeostasis. The mechanistic essence of SIP1 inhibitors revolves around their precision in honing in on the SIP1 protein, an architect of transcriptional dynamics. These inhibitors, strategically designed, exhibit the ability to intricately interfere with SIP1's transcriptional activity and its intricate interactions with other cellular components. This strategic interference bears the ability to modulate the expression patterns of genes under the regulatory purview of SIP1, exerting influence over processes such as EMT and, consequently, dictating cellular behavior.
The ongoing scientific inquiry into SIP1 inhibitors is marked by a meticulous quest to unveil the precise modalities through which these compounds exert their effects. The focus is on unraveling the intricacies of SIP1's transcriptional regulation and its intricate network of interactions within the cellular milieu. The study of SIP1 inhibitors, therefore, emerges as a scientific frontier, offering insights into the molecular nuances that govern cellular development and behavior. The intricate dance orchestrated by SIP1 in regulating gene expression, coupled with its involvement in embryonic development and EMT, positions SIP1 inhibitors as invaluable tools for dissecting the complex interplay between transcriptional dynamics and cellular fate determination. As research advances, the knowledge garnered from SIP1 inhibitors enhances our understanding of the intricate mechanisms underlying cellular development and behavior, contributing to the broader landscape of cellular biology.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Fisetin | 528-48-3 | sc-276440 sc-276440A sc-276440B sc-276440C sc-276440D | 50 mg 100 mg 500 mg 1 g 100 g | $52.00 $79.00 $104.00 $156.00 $2913.00 | 7 | |
May inhibit EMT and SIP1 expression via various molecular pathways. | ||||||
CX-4945 | 1009820-21-6 | sc-364475 sc-364475A | 2 mg 50 mg | $183.00 $800.00 | 9 | |
Inhibits CK2 kinase activity, potentially impacting SIP1 signaling. | ||||||
SB 431542 | 301836-41-9 | sc-204265 sc-204265A sc-204265B | 1 mg 10 mg 25 mg | $82.00 $216.00 $416.00 | 48 | |
Targets TGF-β receptor to inhibit EMT and potentially SIP1-mediated effects. | ||||||
5-Azacytidine | 320-67-2 | sc-221003 | 500 mg | $280.00 | 4 | |
DNA methylation inhibitor, can influence SIP1 expression epigenetically. | ||||||
Resveratrol | 501-36-0 | sc-200808 sc-200808A sc-200808B | 100 mg 500 mg 5 g | $80.00 $220.00 $460.00 | 64 | |
Modulates EMT-related factors like SIP1, potentially through multiple pathways. | ||||||
Salinomycin | 53003-10-4 | sc-253530 sc-253530C sc-253530A sc-253530B | 5 mg 10 mg 25 mg 100 mg | $162.00 $241.00 $406.00 $474.00 | 1 | |
May affect SIP1 and EMT-related pathways in certain cancer cells. | ||||||
Suberoylanilide Hydroxamic Acid | 149647-78-9 | sc-220139 sc-220139A | 100 mg 500 mg | $133.00 $275.00 | 37 | |
HDAC inhibitor with potential effects on gene expression, including SIP1. | ||||||
TAE684 | 761439-42-3 | sc-364626 sc-364626A | 5 mg 50 mg | $188.00 $988.00 | 2 | |
Inhibits NTRK1, ROS1, and ALK, possibly affecting EMT-related pathways. | ||||||
LGK 974 | 1243244-14-5 | sc-489380 sc-489380A | 5 mg 50 mg | $359.00 $1295.00 | 2 | |
Porcupine inhibitor that attenuates Wnt signaling, which may involve SIP1. | ||||||